GLP1R and Insulin resistance: It may be associated with reduction of body weight, blood pressure, the lipid profile and lowering the risk for hypoglycemia, and amelioration of insulin resistance and inflammation, etc. Although our findings were obtained in the context of no obvious heterogeneity among trials, whether the cardiovascular benefits of GLP1R agonists represent a class effect remains to be definitively established.